ADAMTS1 and MMP1 promote breast cancer bone metastasis through a bone stromal cell-mediated osteolytic signaling cascade

被引：0
|
作者：
Lu, Xin
Wang, Qiongqing
Van Poznak, Catherine
Fleisher, Martin
Reiss, Michael
Massague, Joan
Kang, Yibin
机构：
[1] Princeton Univ, Princeton, NJ 08544 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NJ USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Canc Inst New Jersey, New Brunswick, NJ USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5667
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Markers of bone turnover (ICTP, NTX) and serum matrix metalloproteinase 1 (MMP1) as prognostic markers in breast cancer patients (BC) with bone metastases (BM) treated with bisphosphonates (BP)
    Costa, L. A.
    Alho, I.
    Casimiro, S.
    Oliveira, A. G.
    Luis, I.
    Fernandes, A.
    Bicho, M.
    Ali, S. M.
    Leitzel, K.
    Demers, L.
    Lipton, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer
    Yang, Xinghai
    Li, Lei
    Huang, Quan
    Xu, Wei
    Cai, Xiaopan
    Zhang, Jishen
    Yan, Wangjun
    Song, Dianwen
    Liu, Tielong
    Zhou, Wang
    Li, Zhenxi
    Yang, Cheng
    Dang, Yongyan
    Xiao, Jianru
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (02): : 748 - 755
  • [23] HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
    Y Yao
    Z-P Fang
    H Chen
    L Yue
    D-l Min
    L-N Tang
    W-X Yu
    H F Kung
    M C Lin
    Z Shen
    Cancer Gene Therapy, 2012, 19 : 601 - 608
  • [24] HGFK1 INHIBITS BONE METASTASIS IN BREAST CANCER THROUGH THE TAK1/P38 MAPK SIGNALING PATHWAY
    Bu, Y-Z.
    Shen, Z.
    ANNALS OF ONCOLOGY, 2012, 23 : 126 - 126
  • [25] HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
    Yao, Y.
    Fang, Z-P
    Chen, H.
    Yue, L.
    Min, D-I
    Tang, L-N
    Yu, W-X
    Kung, H. F.
    Lin, M. C.
    Shen, Z.
    CANCER GENE THERAPY, 2012, 19 (09) : 601 - 608
  • [26] NAT1 promotes osteolytic metastasis in luminal breast cancer by regulating the bone metastatic niche via NF-κB/IL-1B signaling pathway
    Zhao, Chenglong
    Cai, Xiaopan
    Wang, Yao
    Wang, Dongsheng
    Wang, Ting
    Gong, Haiyi
    Sun, Haitao
    Jia, Qi
    Zhou, Wang
    Wu, Zhipeng
    Li, Zhenxi
    Xiao, Jianru
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (08): : 2464 - +
  • [27] EZH2 engages TGFb signaling to promote breast cancer bone metastasis via Integrin b1-FAK activation
    Zhang, Lin
    Qu, Jingkun
    Qi, Yutao
    Duan, Yimin
    Huang, Yu-Wen
    Zhou, Zhifen
    Li, Ping
    Yao, Jun
    Huang, Beibei
    Zhang, Shuxing
    Yu, Dihua
    CANCER RESEARCH, 2022, 82 (12)
  • [28] LSD1 modulates the bone metastasis of breast cancer cells through hnRNPA2B1-mediated sorting of exosomal miRNAs
    Liu, Ziyu
    Xin, Benkai
    Zhang, Nan
    An, Peipei
    Shi, Yueru
    Yang, Jingtong
    Wan, Youzhong
    He, Yuquan
    Hu, Xin
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [29] LSD1 modulates the bone metastasis of breast cancer cells through hnRNPA2B1-mediated sorting of exosomal miRNAs
    Ziyu Liu
    Benkai Xin
    Nan Zhang
    Peipei An
    Yueru Shi
    Jingtong Yang
    Youzhong Wan
    Yuquan He
    Xin Hu
    Cell Death Discovery, 10
  • [30] Facilitation of Hematopoietic Reconstitution Via Inhibition of Bone Marrow Endothelial Cell-Mediated SDF-1 Signaling
    Doan, Phuong L.
    Russell, J. Lauren
    Himburg, Heather A.
    Meadows, Sarah K.
    Daher, Pamela
    Helms, Katherine
    Quarmyne, Mamle
    Harris, Jeffrey R.
    Reya, Tannishtha
    Chao, Nelson J.
    Kirsch, David G.
    Chute, John P.
    BLOOD, 2010, 116 (21) : 1578 - 1578
12345